tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Ardelyx: Strong Ibsrela Momentum, De-Risked CIC Upside, and Patent-Backed Undervaluation Support Buy Rating
PremiumRatingsArdelyx: Strong Ibsrela Momentum, De-Risked CIC Upside, and Patent-Backed Undervaluation Support Buy Rating
22d ago
Ardelyx reports Q4 EPS 0c, consensus 1c
Premium
The Fly
Ardelyx reports Q4 EPS 0c, consensus 1c
22d ago
Ardelyx Posts Strong 2025 Results, Projects 2026 Growth
Premium
Company Announcements
Ardelyx Posts Strong 2025 Results, Projects 2026 Growth
22d ago
Ardelyx: Commercial Momentum, Expanded Ibsrela Opportunity, and Strengthened IP Underpin Buy Rating
PremiumRatingsArdelyx: Commercial Momentum, Expanded Ibsrela Opportunity, and Strengthened IP Underpin Buy Rating
1M ago
Ardelyx announces first patient dosed in ACCEL
Premium
The Fly
Ardelyx announces first patient dosed in ACCEL
1M ago
3 Best Stocks to Buy Today, 1/27/2026, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Today, 1/27/2026, According to Top Analysts
2M ago
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
PremiumThe FlyArdelyx upgraded to Overweight from Neutral at Piper Sandler
2M ago
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
Premium
The Fly
Ardelyx upgraded to Overweight from Neutral at Piper Sandler
2M ago
Ardelyx price target raised to $19 from $16 at Raymond James
Premium
The Fly
Ardelyx price target raised to $19 from $16 at Raymond James
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100